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Summary A meta-analysis was performed on three case controlled studies which
examined the relationship between latent toxoplasmosis gondii infection in the
immunocompetent host and cryptogenic epilepsy. Further comparison was also made
by examining the seroprevalence of toxoplasmosis rates for 17 various countries,
cities or regions against the prevalence rates for epilepsy in those regions.
Results: The results for the meta-analysis showed a log-odds ratio of 4.8 which
approximates to a similar relative risk, (CI 2.6 to 7.8), with CI for all three studies
being above 1. Seroprevalence rates for toxoplasmosis and prevalence rates of
epilepsy showed a strong association ( p < 0.001).
Discussion: The prevalence of toxoplasmosis is an important factor in the prevalence
of epilepsy with a probable link in the cryptogenic epilepsies. An area with a reduced
burden of toxoplasmosis will also have a reduced burden of epilepsy. Neuropatho-
physiology findings from various studies show a common physical relationship of
microglial nodule formation in Toxoplasma gondii infection and epilepsy. This analysis
raises the possibility that one of the many causes of epilepsy may be an infectious
agent, or that cryptogenic epilepsy may be a consequence of latent toxoplasmosis
infection. This raises the possibility that public health measures to reduce toxoplas-
mosis infection may also result in a reduction in epilepsy.
# 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.* Correspondence address: 27 Langley Meadows, Loughton,
Essex IG10 2DL, United Kingdom.
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Epilepsy, like anaemia is a sign with many causes,
with 1% of the general population being affected.1
However, about 20% of epileptic patients have an. Published by Elsevier Ltd. All rights reserved.
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The short-term consequences of toxoplasmosis are
well known–—a short flu like illness, with no reported
long-term consequences. In chronic toxoplasmosis
infection the organism can live in any of the body
tissues, with a predisposition for the brain and
muscle3 and remains alive for the whole life of
the individual with no apparent ill effects.
Immunocompromised individuals are at risk of
reactivating a latent toxoplasmosis infection. In
the brain, toxoplasma encephalitis can develop
or, if situated in any other tissues abscesses may
form.4,5 This paper endeavours to determine if
Toxoplasma gondiimay be associated with epilepsy.Method
For the meta-analysis a database search for case—
control studies of toxoplasmosis and epilepsy, using
the Cochrane database and Medline: search terms
were: [toxoplasmosis or Toxoplasma gondii] and
[epilepsy or cryptogenic, epidemiology of epilepsy]
were conducted. The complete yield of results was
only three case—controlled studies, none of the
three were excluded from this meta-analysis.
The data were analysed using STATA statistical
software; the odds ratios from each study were
combined using a random-effects model.
An ecological study was also conducted. Studies
documenting the prevalence of epilepsy in specified
countries were sought. (Search terms used were:
epidemiology of epilepsy, prevalence, population
based study) Separately studies documenting the
prevalence of toxoplasmosis in specified countries
were sought. (Search terms used were: epidemiol-
ogy of toxoplasmosis, seroprevalence, prevalence,
Toxoplasma gondii, pregnant) and all countries
for which an estimate of the prevalence of bothigure 1 Log-odds ratio forest plot for the three above studies. Turkish study the log-odds ratio is 5.3 (CI 2.1—13.3),
ew England study the log-odds ratio is 12.2 (CI 3.0—49.9), Israeli study the log-odds ratio is 2.8 (CI 1.2—6.3). Combined
g-odds ratio is 4.8 (CI 2.6—7.8). There was no heterogeneity between studies.F
N
loepilepsy and toxoplasmosis were identified. Neces-
sarily the overall prevalence of epilepsy was docu-
mented rather than the prevalence of cryptogenic
epilepsy or other subgroups because such data were
infrequently documented.
Seroprevalence of toxoplasmosis was reported
either in pregnant women in a country or region
(Fig. 2) or seroprevalence throughout a general popu-
lation (Fig. 3). The prevalence of both toxoplasmosis
and epilepsy have been falling over the last few
decades6—8 so countries or regions were included
only if the time difference between the estimates
of toxoplasmosis and epilepsy was less than 20 years.
A scatter plot from the combined data obtained
in Figs. 2 and 3 has also been performed (Fig. 4).
Studies were searched for on the Cochrane data-
base as well as the ‘Medline’ site, which is a division
of U.S. National Library of Medicine, using the
search terms stated above.Results
Three case-control studies were identified and
included in the meta-analysis shown in Fig. 1.9—11
In the meta-analysis itself the size of the squares are
proportional to the size of the study. The prevalence
of toxoplasmosis in epileptics and controls in each
study are shown in Table 1. The summary odds ratio
(approximating a relative risk) from the three stu-
dies is 4.8 (95% confidence interval (2.6 to 7.8)),
indicating that epilepsy is 4.8 times more prevalent
among persons seropositive for toxoplasmosis than
the seronegative ones. There was no heterogeneity
between the studies.
The ecological study showed a strong associa-
tion between the prevalence of epilepsy in coun-
tries, cities or regions and the seroprevalence of
toxoplasmosis both in pregnant women (Fig. 2) and
Meta-analysis of three case controlled studies and an ecological study 659
Table 1 Occurrence of toxoplasmosis in epileptic patients in the three studies under analysis
Outcome Study group Control group Total
Turkish Study7, pub 2003, p-value <0.01
Toxo +ve 27 9 36
Toxo ve 23 41 64
Total 50 50 100
New England Study8,a, pub 2001, p-value 0.013
Toxo +ve 17 5 22
Toxo ve 5 18 23
Total 22 23 45
Israeli Study9, pub 1995, p-value 0.11 (0.03 for any neurological disorder)
Toxo +ve 21 10 31
Toxo ve 74 99 173
Total 95 109 204
*Using figures for the study as a whole, which included epilepsy, cerebral palsy and nerve deafness and their relationship with
toxoplasmosis. In the Israeli study they were studying cerebral palsy, epilepsy and nerve deafness, the exact number in each group
was unknown but a third of the total group was implied, 32 is an underestimated figure.
a For the control group, the paper stated a background rate of 20% for seroprevalence of toxoplasmosis. It was unclear if this was the
figure the paper had obtained which is also the standard background prevalence in this part of the U.S.A.the general population (Fig. 3) within the same
region. The scatter plot (Fig. 4) shows a strong
association ( p < 0.001) between the seropreva-
lence of toxoplasmosis and the prevalence of epi-
lepsy, both in pregnant women (r = 0.98) and in the
general population (r = 0.91).Discussion
The meta-analysis shows that epilepsy especially
cryptogenic epilepsy, may to some degree, be asso-Figure 2 Graph comparing seroprevalence of toxoplasmosi
epilepsy per 1000 of general population, by country. Words
compared. References given are bold for epilepsy and italics
area. In the remainder of Pakistan the rates that have beenciated with toxoplasmosis. The ecological study and
the scatter plot both show an association. A regres-
sion line has not been placed on the scatter plot as
the association may appear exaggerated and may be
due to confounding.
In Figs. 2 and 3 a trend is seen, in that the higher
the seroprevalence of toxoplasmosis, the higher the
rate of epilepsy in the population. It should be noted
that in the majority of the above studies (Figs. 2 and
3) there was increased seroprevalence of toxoplas-
mosis antibodies with advancing age, low economic
status and low educational background. While somes for pregnant women (percentage of population) against
in brackets are regions or areas from which data was
for toxoplasmosis.#This toxoplasmosis rate is high in this
reported are much lower.
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Figure 3 Graph comparing seroprevalence of toxoplasmosis in general population (percentage of population) against
epilepsy per 1000 of general population, by country. Words in brackets are regions or areas from which data was
compared. References given are bold for epilepsy and italics for toxoplasmosis.^Seroprevalence of toxoplasmosis in
Enawene-Nawe tribe in the Brazilian state of Mato Grosso.*Epilepsy rate for active epilepsy was reported as 12.4%,
inactive was 6.2% and a total prevalence given as 18.6% for the Bakairi Indians, in the Brazilian state of Mato
Grosso.Prevalence in population were given as 5.4% were positive for IgM and 4.66% showed IgG antitoxoplasma
antibodies. Thus, a total prevalence is stated as 10 in this report.studies showed a higher rate in rural areas compared
to urban areas, many did not.10,12—14 This was
usually due to other factors regarding cat owner-
ship, contact with soil, age, social status and eco-
nomic differences in the populations being studied
or cultural differences.10,14—17
As can be seen from Fig. 3, the Brazilian statis-
tics, while holding true to observed relationship of
‘high toxoplasmosis rate, high epilepsy rate’, the
epilepsy rate seems disproportionately large. There
are various possible reasons for this; themost logicalFigure 4 Scatter plot combining the data from Fig. 2 and 3 s
women (diamonds) and the general population (squares) agai
Grosso has been excluded from the scatter plot as it is an
coefficients show a strong association ( p < 0.001) between th
epilepsy, both in pregnant women (r = 0.98) and in the generis that there are many causes of epilepsy, toxoplas-
mosis being one cause. Also the poorer a region, the
higher the morbidity afflicting that region, this
relationship is demonstrated in Fig. 2, where the
lowest rates for epilepsy and toxoplasmosis come
from wealthy countries and the highest come from
less well off or countries with poorer living stan-
dards for the general population.
Whether toxoplasmosis is a confounding factor in
epilepsy should be relatively easy to disprove. It
should be possible to find a country, area or cityhowing the seroprevalence of toxoplasmosis for pregnant
nst prevalence of epilepsy. The data point for Brazil Mato
outlier and skews the remaining data. The correlation
e seroprevalence of toxoplasmosis and the prevalence of
al population (r = 0.905).
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epilepsy is very high or vice versa. Although this is an
easy task to perform for other diseases that are
suspected of causing some forms of epilepsy, for
example CMV. The CMV rate in Hong Kong is over 80%
compared to the low rate of epilepsy, which is 1.54
per 1000. This is not so for toxoplasmosis, indeed no
country, city or region which goes against this trend
could be found, unless like with like was not com-
pared. Some regions in India or Pakistan show a high
epilepsy rate while other regions show a low tox-
oplasmosis rate, but when a same/similar region or
a similar ethnic group is compared within a region
the relationship of high toxoplasmosis rate and high
epileptic rate still appears to holds true.
The above trend is also confirmed by the gradual
decline over the decades seen in the incidence of
cryptogenic epilepsy11 and toxoplasmosis.3,10 The
prevalence of epilepsy is falling over time, as is
toxoplasmosis, the fall in the rate of toxoplasmosis
is due to increased personal and food hygiene, and
the precautions taken in the preparation of red
meats. For pregnant ladies, the advice of not eating
undercooked meat and taking care when changing
the cat litter tray have all had an effect on the
reduction of the toxoplasmosis rate. Although there
are vaccine candidates for toxoplasmosis gondii,18
none have been proven and as toxoplasmosis gondii
belongs to the same phylum (Apicomplexa) as
malaria, such a vaccine maybe exceptionally diffi-
cult to obtain.
Proposed pathophysiology of how
Toxoplasma gondii could cause epilepsy
The tissue cyst distribution of Toxoplasma gondii is
dependent on the immunocompetency of the host,
epigenetics of the host and the strain of T. gondii. In
animal models it is proposed that some tissue cysts
rupture and in doing so causes marked inflammation
of that area and hence triggers microglial formation
which may represent the ‘tombstones’ of Toxoplams
cysts18 and lead to scar tissue formation. It has also
been demonstrated that the formation of new gen-
eration of tissue cysts is possible in chronically
infected mice, but the mechanism of exit and entry
into a cell, is as yet not fully understood.19 Microglial
nodules have also been found in some viral dis-
eases,20—22 and have been described in patients with
glioneuronal tumors.23 This may account for the
finding that not all cryptogenic epileptics test posi-
tive for Toxoplasma gondii. However, when compar-
ing theprevalence rates of epilepsywith thoseofCMV
seroprevalence, there was no correlation.
In epilepsy the formation of scar tissue has been
suggested to be one of the main theories for thecause of epilepsy and has been supported by many
studies.
Scar tissue in the brain can be present due to
many kinds of pathology initially microglial are
prominent after the initial insult. After a period
of time, a dense fibrous gliosis is laid down; how
microglia are related to the formation of scar tissue
is unknown, but seem to be related, the microglia
being the first step in this pathology24,25. It should
be noted that the incidence or prevalence of micro-
glial nodules in the general population could not be
found.
Another possible initiation event for an epileptic
seizure is when T. gondii has entered the cell, it is
then able to hijack the host cell Ca2+ pump. When T.
gondii exits the host cell there is a rise in [Ca2+] in
the host which allows T. gondii to escape and sub-
sequent lysis of the host cell occurs26. This lysis will
also cause microglial formation18.
Epileptic discharge may occur with a membrane
defect leading to instability of the resting potential
and/or abnormalities of potassium conductance,
calcium channels, GABA inhibitory system27. In ani-
mal models, ablation of Ca channels does demon-
strate seizure resistance28 and differing membrane
permeability to Ca2+ does lead to a change in the
firing threshold of the affected neurone29. Whether
Toxoplasma’s ability to change the [Ca2+] within the
cell of which it resides could be a pathway to induce
an epileptic seizure is unknown but remains a pos-
sibility.Conclusion
The evidence presented in this study seems to indi-
cate that toxoplasmosis is a disease of age, social
and economic poverty. The risks of which are
reduced with increased economic prosperity and
health provision.
The prevalence of toxoplasmosis is an associated
factor in the prevalence of over-all epilepsy with a
more probable link in the cryptogenic epilepsies. An
area with a reduced burden of toxoplasmosis will
also appear to have a reduced burden of epilepsy.
The neuropathophysiology findings from various
studies18,25,30 show that there is a physical relation-
ship of microglial nodule formation in Toxoplasma
gondii infection and in epilepsy. Whether this pro-
vides data to support the concept that one of the
many causes of epilepsy may be an infectious agent
or that cryptogenic epilepsy is a consequence of
latent toxoplasmosis infection may only be con-
firmed with a more directed study.
There is clearly an association between toxoplas-
mosis and epilepsy and an association is plausible,
662 B.S. Palmerbut this association may be exaggerated by con-
founding in the data (that is, people with toxoplas-
mosis may be more likely to have other causes of
epilepsy). Other work that could be performed to
take this theory forward could be larger case con-
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